Hruban RH - Search Results

1

Deleterious Germline Mutations Are a Risk Factor for Neoplastic Progression Among High-Risk Individuals Undergoing Pancreatic Surveillance.

Abe T, Blackford AL, Tamura K, Ford M, McCormick P, Chuidian M, Almario JA, Borges M, Lennon AM, Shin EJ, Klein AP, Hruban RH, Canto MI, Goggins M. Abe T, et al. Among authors: hruban rh. J Clin Oncol. 2019 May 1;37(13):1070-1080. doi: 10.1200/JCO.18.01512. Epub 2019 Mar 18. J Clin Oncol. 2019. PMID: 30883245 Free PMC article.

2

Intrahepatic, extramedullary hematopoiesis mimicking hemangioma on technetium-99m red blood cell SPECT examination.

Tamm EP, Rabushka LS, Fishman EK, Hruban RH, Diehl AM, Klein A. Tamm EP, et al. Among authors: hruban rh. Clin Imaging. 1995 Apr-Jun;19(2):88-91. doi: 10.1016/0899-7071(94)00037-d. Clin Imaging. 1995. PMID: 7773882 Free article.

3

Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma.

DiGiuseppe JA, Hruban RH, Offerhaus GJ, Clement MJ, van den Berg FM, Cameron JL, van Mansfeld AD. DiGiuseppe JA, et al. Among authors: hruban rh. Am J Pathol. 1994 May;144(5):889-95. Am J Pathol. 1994. PMID: 8178941 Free PMC article.

4

Overexpression of p53 protein in adenocarcinoma of the pancreas.

DiGiuseppe JA, Hruban RH, Goodman SN, Polak M, van den Berg FM, Allison DC, Cameron JL, Offerhaus GJ. DiGiuseppe JA, et al. Among authors: hruban rh. Am J Clin Pathol. 1994 Jun;101(6):684-8. doi: 10.1093/ajcp/101.6.684. Am J Clin Pathol. 1994. PMID: 8209852

5

Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas.

Goggins M, Schutte M, Lu J, Moskaluk CA, Weinstein CL, Petersen GM, Yeo CJ, Jackson CE, Lynch HT, Hruban RH, Kern SE. Goggins M, et al. Among authors: hruban rh. Cancer Res. 1996 Dec 1;56(23):5360-4. Cancer Res. 1996. PMID: 8968085

6

Tumor-suppressive pathways in pancreatic carcinoma.

Rozenblum E, Schutte M, Goggins M, Hahn SA, Panzer S, Zahurak M, Goodman SN, Sohn TA, Hruban RH, Yeo CJ, Kern SE. Rozenblum E, et al. Among authors: hruban rh. Cancer Res. 1997 May 1;57(9):1731-4. Cancer Res. 1997. PMID: 9135016

7

Pancreatic adenocarcinomas with DNA replication errors (RER+) are associated with wild-type K-ras and characteristic histopathology. Poor differentiation, a syncytial growth pattern, and pushing borders suggest RER+.

Goggins M, Offerhaus GJ, Hilgers W, Griffin CA, Shekher M, Tang D, Sohn TA, Yeo CJ, Kern SE, Hruban RH. Goggins M, et al. Among authors: hruban rh. Am J Pathol. 1998 Jun;152(6):1501-7. Am J Pathol. 1998. PMID: 9626054 Free PMC article.

8

Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression.

Wilentz RE, Geradts J, Maynard R, Offerhaus GJ, Kang M, Goggins M, Yeo CJ, Kern SE, Hruban RH. Wilentz RE, et al. Among authors: hruban rh. Cancer Res. 1998 Oct 15;58(20):4740-4. Cancer Res. 1998. PMID: 9788631

9

Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas.

Goggins M, Shekher M, Turnacioglu K, Yeo CJ, Hruban RH, Kern SE. Goggins M, et al. Among authors: hruban rh. Cancer Res. 1998 Dec 1;58(23):5329-32. Cancer Res. 1998. PMID: 9850059

10

Tumor-suppressor genes in pancreatic cancer.

Hruban RH, Offerhaus GJ, Kern SE, Goggins M, Wilentz RE, Yeo CJ. Hruban RH, et al. J Hepatobiliary Pancreat Surg. 1998;5(4):383-91. doi: 10.1007/s005340050062. J Hepatobiliary Pancreat Surg. 1998. PMID: 9931387 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,060 results

Search Page